Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 55.53
-1.55 (-2.72%)
Apr 29, 2026, 3:04 PM CST
SHE:002653 Revenue
In the year 2025, Haisco Pharmaceutical Group had annual revenue of 4.39B CNY with 17.91% growth. Haisco Pharmaceutical Group had revenue of 1.09B in the quarter ending December 31, 2025, with 12.12% growth.
Revenue
4.39B
Revenue Growth
+17.91%
P/S Ratio
12.51
Revenue / Employee
904.01K
Employees
5,597
Market Cap
63.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.39B | 666.44M | 17.91% |
| Dec 31, 2024 | 3.72B | 366.28M | 10.92% |
| Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
| Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
| Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Wantai Biological Pharmacy Enterprise | 1.82B |
| Pharmaron Beijing | 14.10B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Asymchem Laboratories (Tianjin) | 6.67B |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Shanghai RAAS Blood Products | 7.35B |
| Chongqing Zhifei Biological Products | 10.91B |
Haisco Pharmaceutical Group News
- 11 days ago - As China’s biotech firms shift gears, can AI floor the accelerator? - South China Morning Post